Vaccines
FDA Approves Moderna’s mFlusiva, the First mRNA Flu Vaccine
Cleared for adults 50 and older, the shot cut confirmed influenza by 27% versus a standard vaccine in 50-to-64-year-olds — a landmark for mRNA beyond COVID.